Melius Microbiomics
Founded 2023 · 17 employees on LinkedIn · 1 known investors
Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.
Founders & leadership
Melius Microbiomics was founded in 2023 by Dr. Deanna Gibson, Robert Emlyn, and Celinka Zhou.
DD
Dr. Deanna GibsonCo-Founder
RE
Robert EmlynCo-Founder & Chief Executive Officer
CZ
Celinka ZhouCo-Founder & Executive VP, Corporate Development & Capital Markets
KH
Kevin HorganHead of Research & Development
Investors · 1
Frequently asked questions
- What does Melius Microbiomics do?
- Melius MicroBiomics develops microbiome-based live biotherapeutics (its GEMM technology) to treat chronic inflammatory diseases, pursuing both human and animal health applications. The company's therapies originate from patented research at the University of British Columbia Okanagan's Gibson Lab.
- Who founded Melius Microbiomics?
- Melius Microbiomics was founded by Dr. Deanna Gibson, Robert Emlyn, Celinka Zhou in 2023.
- Who are Melius Microbiomics's investors?
- Melius Microbiomics's investors include Innovation UBC.